FLNA and Rab7 protein expressions were significantly decreased compared to Con, whereas the level of lysosome marker, LAMP1, was significantly increased in pre-AD and MCI stage group serums compared to Con (Figure 7). Here, LAMP1 is linked to Alzheimer disease.